James Auran, MD, a professor of ophthalmology at Columbia University Irving Medical Center and president of the American Society of Ophthalmic Trauma, explains what he is most looking forward to at the 2021 conference of the American Academy of Ophthalmology (AAO).
The field of ophthalmic trauma began to receive more attention around 2 or 3 years ago, explained James Auran, MD, a professor of ophthalmology at Columbia University Irving Medical Center and president of the American Society of Ophthalmic Trauma. Auran will chair a session at the American Academy of Ophthalmology's 2021 conference, taking place November 12-15, on the responsibilities of the on-call ophthalmologist.
Transcript
What are you most looking forward to at the American Academy of Ophthalmology's 2021 conference?
I'm Dr Jim Auran. I'm a professor of ophthalmology at Columbia University and I've had the honor of being president of the American Society of Ophthalmic Trauma for the past 2 years. I think what I'm looking forward to most is that we have some pretty comprehensive instruction courses going, all because of the gracious efforts of the academy to allow us to do so. We have a poster session and a symposium. Trauma has been the poor stepchild of ophthalmology for a long time. There's been a tremendous amount of interest and many people have dedicated their lives to it, but they hadn't got the traction until recently. I guess it just hit a critical point about 2 to 3 years ago and here we are.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Global Status of HIV/AIDS Pandemic Takes Center Stage in Opening Session
March 10th 2025The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about the progress, and lack of progress, that has been made in the fight against the HIV pandemic given the current political climate.
Read More
HIVconsvX Vaccine Shows Safety, Immune Response in People on ART
March 10th 2025This research on a T-cell–targeting vaccine in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of immune reconstitution.
Read More